文献速递类风湿关节炎其他结缔组织病

转录共激活因子Bob1与自身免疫组织炎症中的病理性B细胞反应相关

The Transcriptional Coactivator Bob1 Is Associated With Pathologic B Cell Responses in Autoimmune Tissue Inflammation.
PubMed 文献 · Arthritis Rheumatol · 2017-03-07

本研究通过RA滑膜炎基因表达谱发现Bob1及其靶基因BCMA显著上调,并在CIA模型中证实B细胞特异性Bob1缺失可阻断生发中心形成、抗CII抗体产生和关节炎发生。人类RA和原发性干燥综合征组织中Bob1表达与生发中心标志物CD21L强相关,提示Bob1是病理性B细胞反应的候选分子开关。

要点

  • RA滑膜炎中Bob1及其靶基因BCMA显著上调,B细胞中Bob1表达升高。
  • Bob1缺陷小鼠不能产生致病性抗CII抗体,对CIA抵抗。
  • B细胞特异性Bob1缺失阻断生发中心B细胞形成、抗CII抗体产生和CIA发展。

核心结论

  • Bob1是自身免疫疾病中病理性B细胞反应的候选分子开关。

研究设计与样本

  • 对RA滑膜炎进行基因表达谱分析,并用定量PCR和免疫组化验证。
  • 在胶原诱导性关节炎(CIA)模型中评估Bob1对病理性B细胞反应的作用。
  • 将Bob1缺陷与Bob1充足小鼠的细胞过继转移至重组激活基因1缺失小鼠。
  • 对RA滑膜炎和原发性干燥综合征腮腺组织进行免疫表型分析。

主要发现

  • RA滑膜炎转录谱显示B细胞特征,Bob1和BCMA是最上调基因之一。
  • Bob1缺陷小鼠不能产生致病性抗II型胶原(抗CII)抗体,对CIA抵抗。
  • B细胞特异性Bob1缺失阻断生发中心B细胞形成、抗CII抗体产生和CIA发展。
  • 人B细胞亚群中Bob1表达升高,主要见于中心细胞和中心母细胞。
  • RA滑膜炎中Bob1表达与生发中心分子标志物CD21L强相关,原发性干燥综合征腮腺组织中类似。

关键数值与推荐

  • RA滑膜炎中Bob1和BCMA为最上调基因之一。
  • Bob1缺陷小鼠对CIA抵抗,不产生致病性抗CII抗体。
  • B细胞特异性Bob1缺失阻断生发中心B细胞形成、抗CII抗体产生和CIA发展。
  • RA滑膜炎中Bob1表达与CD21L强相关。

临床怎么用

  • Bob1可能作为自身免疫病病理性B细胞反应的生物标志物或治疗靶点。
  • RA和原发性干燥综合征中Bob1与生发中心标志物CD21L相关,提示其参与异位生发中心形成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The molecular mechanisms steering abnormal B cell responses in autoimmune diseases remain poorly understood. We undertook this study to identify molecular switches controlling pathologic B cell responses in rheumatoid arthritis (RA). METHODS: Candidate molecules were identified by gene expression profiling of RA synovitis and validated by quantitative polymerase chain reaction and immunohistochemistry. B cell-specific expression was confirmed by immunofluorescence, immunoblotting, and flow cytometry. The role of Bob1 in pathologic B cell responses was assessed in collagen-induced arthritis (CIA). RESULTS: Transcriptional profiling of RA synovitis revealed a prominent B cell signature, with the transcriptional coactivator Bob1 and its putative target BCMA being among the most up-regulated genes. Further analysis confirmed the microarray data and demonstrated elevated levels of Bob1 in B cells in RA synovium. A functional study showed that Bob1-deficient mice failed to produce pathogenic anti-type II collagen (anti-CII) antibodies and were resistant to CIA. Adoptive transfer of cells from Bob1-deficient and Bob1-sufficient mice to recombination-activating gene 1-null mice demonstrated that Bob1 deficiency exclusively in B cells abrogated germinal center (GC) B cell formation, anti-CII antibody production, and CIA development. Consistent with data from animal studies, immunophenotyping of human B cell subsets revealed increased expression of Bob1, predominantly in centrocytes and centroblasts. Correspondingly, Bob1 expression in RA synovitis was strongly correlated with CD21L, a molecular marker of GCs. In addition, similar Bob1 overexpression and correlation with CD21L expression was evidenced in parotid salivary gland tissue from patients with primary Sjögren's syndrome. CONCLUSION: These expression and functional data identify the transcriptional coactivator Bob1 as a candidate molecular switch of pathogenic B cell responses in autoimmune diseases in humans.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Levels MJ, Van Tok MN, Cantaert T, et al. The Transcriptional Coactivator Bob1 Is Associated With Pathologic B Cell Responses in Autoimmune Tissue Inflammation. Arthritis Rheumatol. 2017. PMID: 27907250. doi:10.1002/art.39993

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。